7Baggers
 Lineage Cell Therapeutics Hits New 52-Week High of $1.72  Markets Mojo Mon, 29 Sep 2025 16:36:43 GMT
 Lineage Cell Therapeutics Hits New 52-Week High of $1.63  Markets Mojo Wed, 24 Sep 2025 14:35:06 GMT
 lineage cell therapeutics hits new 52-week high of $1.61  Markets Mojo Fri, 19 Sep 2025 11:08:49 GMT
 lineage cell therapeutics hits new 52-week high of $1.61  Markets Mojo Thu, 18 Sep 2025 07:00:00 GMT
 united states stem cell therapy market expansion driven  openPR.com Thu, 18 Sep 2025 07:00:00 GMT
 published on: 2025-09-15 21:14:53  خودرو بانک Mon, 15 Sep 2025 17:43:33 GMT
 Lineage Cell Therapeutics at H.C. Wainwright: Advancing Cell Therapies  Investing.com Mon, 08 Sep 2025 07:00:00 GMT
 Lineage Nabs $12M Demant Partnership  San Diego Business Journal Mon, 08 Sep 2025 07:00:00 GMT
 published on: 2025-09-06 02:25:51  خودرو بانک Sat, 06 Sep 2025 09:26:38 GMT
 published on: 2025-09-04 04:56:57  Newser Thu, 04 Sep 2025 09:56:57 GMT
 published on: 2025-09-04 08:56:10  خودرو بانک Thu, 04 Sep 2025 05:27:41 GMT
 published on: 2025-09-03 23:32:42  Newser Thu, 04 Sep 2025 04:32:42 GMT
 new report: cell therapy manufacturing market set for rapid  openPR.com Wed, 03 Sep 2025 08:45:54 GMT
 published on: 2025-09-02 15:54:56  Newser Tue, 02 Sep 2025 20:54:56 GMT
 published on: 2025-09-02 13:14:02  Newser Tue, 02 Sep 2025 18:14:02 GMT
 published on: 2025-09-01 11:20:15  Newser Mon, 01 Sep 2025 16:20:15 GMT
 published on: 2025-08-30 21:37:55  Newser Sun, 31 Aug 2025 02:37:55 GMT
 published on: 2025-08-30 20:41:18  Newser Sun, 31 Aug 2025 01:41:18 GMT
 lineage announces research collaboration to develop resonance for hearing loss  The Hearing Review Sat, 30 Aug 2025 01:06:24 GMT
 published on: 2025-08-29 04:06:39  Newser Fri, 29 Aug 2025 09:06:39 GMT
 published on: 2025-08-29 03:19:56  Newser Fri, 29 Aug 2025 08:19:56 GMT
 Lineage Announces Research Collaboration to Develop ReSonance for Hearing Loss  The Hearing Review Fri, 29 Aug 2025 07:00:00 GMT
 published on: 2025-08-29 01:15:05  Newser Fri, 29 Aug 2025 06:15:05 GMT
 published on: 2025-08-29 00:10:37  Newser Fri, 29 Aug 2025 05:10:37 GMT
 published on: 2025-08-28 16:30:18  Newser Thu, 28 Aug 2025 21:30:18 GMT

Lineage Cell Therapeutics, Inc
(NYSE MKT:LCTX) 

LCTX stock logo

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. The company's lead product candidates include OpRegen, a retinal pigment epithelium cell r...

Full Time Employees: 50
CEO: Brian M. Culley  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends